A diagnosis of a lipoma of the chest wall was made.
At operation the mass was found to be an encapsulated multilobular lipoma (Fig. 2 ) lying deep to pectoralis major and minor and superficial to the chest wall. It was enucleated without difficulty. Section of the tumour showed it to be a typical lipoma. (Fig. 3 ). m oS l p õ~~~~H matoylin eosin show appearance
The interest of this case lies in the bizarre appearance produced by a lipoma of chest wall, so placed as to resemble at first glance a gross unilateral enlargement of the male breast.
Mr. R. Kenneth Bowes: I agree with Mr. Williams' diagnosis of a subpectoral lipoma. The physical signs seem very characteristic of this condition. I remember a very similar case in a female patient in whom there had appeared to be unilateral hypertrophy of the breast but the main mass of tissue could be demonstrated to be under the pectoralis major and was quite separate from the gland. At operation it was found to be a lipoma.
Mr. Selwyn F. Taylor: I would suggest that this tumour of the breast may be a hamartoma. I have operated upon a somewhat similar one which proved to be exceedingly vascular and the pathologists provided this diagnosis. Perhaps it might b le at t glnce ago mesenchymoma, a connective tissue neoplasm of immature vascular, fibrous and adipose tissue. In 1945 a diagnosis of chronic myeloid leukaemia had been made elsewhere on the finding of gross splenomegaly and on the appearance of the peripherat blood (see Table I ), and some Proceedings of the Royal Society -of Medicine radiotherapy was given in that year. In 1948, in view of the small numbers of primitive cells in the peripheral blood, no treatment was given. In the following year the diagnosis was revised to that of leuko-erythroblastic anaemia because of the presence in the peripheral blood of primitive white and red cells, together with the finding of a normal sternal marrow smear. In May 1950 the final diagnosis of myelofibrosis was established by sternal marrow trephine biopsy (see Fig. 1 ). Up to March 1951 only two transfusions had been necessary to keep the hkmoglobin at about 800%, but from this time the rate of fall began to increase, excessive htmolysis was apparent in increased pigment excretion and frequently repeated transfusions became necessary (see Fig. 2 ). In July the rate of destruction of Group 0 donor cells was found by differential agglutination to be greatly increased. In August, during a month's trial of cortisone therapy, the rate of destruction was found not to differ significantly. (These studies were kindly carried out by Dr. H. Chaplin of the Blood Transfusion Research Unit, Post-graduate Medical School of London.)
Since this time the fall of hemoglobin continues unchanged. Transfusion is necessary at frequent intervals since cardiac failure supervenes at about 500% hemoglobin, even with bed-rest. Reticulocytes are constantly less than 2%. The white count is now only slightly raised and there are no primitive cells in the peripheral blood. The platelet count is normal and there is no bleeding tendency. The spleen reaches to the pubic symphysis, the liver edge is palpable 3 inches (7 5 cm.) below the right costal margin but there is no palpable lymph-gland enlargement. Bone X-rays show no abnormality. Comment.-The technical difficulty of removing such a vast spleen is likely to be considerable and some extra-medullary hematopoiesis may be occurring in the spleen. It is felt, however, that the spleen may be playing a prominent part in the rapid red cell destruction and that it may also be suppressing any remaining marrow function (Edwards, H. C., 1951, Lancet, ii, 601) .
Frequent transfusions are becoming more and more difficult because of shortage of veins and, in addition, the risk of reactions connected with rare blood groups becomes greater as time goes on. Splenectomy seems to offer the only hope of reducing the rate of cell destruction. Even if the operation produced at the same time a virtual secondary aplastic anxmia the removal of the htmolytic element should put the patient in a better position regarding transfusion requirements than at present. The President: One of the many interesting features of this case is the failure of cortisone to lengthen the life of the red corpuscle. There has recently been a suggestion that cortisone produces a beneficial effect in acquired hvmolytic anxmia, and that it may in familial htmolytic anaemia be used as a pre-splenectomy measure because of this beneficial action. I should certainly be in favour of splenectomy for this patient. It is clear that she is now going downhill rapidly, and that blood transfusions are becoming progressively less effective. She would indeed benefit considerably from removal of this large splenic tumour even if it had no direct effect upon the rate of hemolysis. However, it is highly probable that its removal will also have the effect of prolonging the life of the erythrocytes; and although for this condition splenectomy is not curative, it is likely to prolong the patient's life considerably. The risk of operation is clearly less than was the case before antibiotics and blood transfusions were so readily available. It cannot be denied, however, that the operation is not entirely free from risk. In my opinion, that risk is justifiable in this patient.
Further report.-17.10.51: Splenectomy was carried out by Mr. R. H. Boggon. The spleen measured 26 x 14 x 8 cm. Smears and sections showed neutrophil and eosinophil granulopoiesis but no erythropoiesis.
Two days after operation a 10% reticulocytosis occurred and the hxmoglobin climbed from 820% to 100% in ten days. White cells rose from 14,600 (polymorphs 93 %) to 54,900 (polymorphs 100%) in two days. Platelets rose from 110,000 to 838,000 in a week.
15.11.51: The patient feels very well. Blood values are: Hb 1050%; white cells 37,000 (P. 93 %, L. 5%, E. 2 %); platelets 980,000.
A further study of donor-cell survival is being made and a report will be made to the Section in due course.-R. B. F. 4£
